Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

Michael G. Kaplitt, Andrew Feigin, Chengke Tang et al. · The Lancet · 2007 · 1.1K citations

Adeno-associated Virus, Medical Treatment, Borne Gad Gene +4

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

William J. Marks, Jill L. Ostrem, L. Verhagen et al. · The Lancet Neurology · 2008 · 581 citations

Neurodegenerative Diseases, Idiopathic Parkinson, Medicine +4

Genetic variation in human NPY expression affects stress response and emotion

Zhifeng Zhou, Guanshan Zhu, Ahmad R. Hariri et al. · Nature · 2008 · 451 citations · Full text

Stress Hormone, Stress, Genetics +9

Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression

Annika Thorsell, M Michalkiewicz, Yvan Dumont et al. · Proceedings of the National Academy of Sciences · 2000 · 313 citations · Full text

Npy Peptide, Affective Neuroscience, Locomotor Activity +17

Electrophysiologic Analysis of a Chronic Seizure Model After Unilateral Hippocampal KA Injection

Anatol Bragin, Jerome Engel, Charles L. Wilson et al. · Epilepsia · 1999 · 307 citations · Full text